VALIRX PLC Logo

VALIRX PLC

Life science company developing therapeutics for oncology and women's health.

VAL | IL

Overview

Corporate Details

ISIN(s):
GB00BLH13C52
LEI:
213800VQKB9SJCQDET40
Country:
United Kingdom
Address:
STONEBRIDGE HOUSE, CM22 7BD HATFIELD HEATH

Description

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-05 12:10
Holding(s) in Company
English 52.9 KB
2025-11-24 17:05
Holding(s) in Company
English 52.8 KB
2025-11-24 10:40
Holding(s) in Company
English 21.0 KB
2025-11-20 13:25
Result of GM & Issue of Equity
English 58.4 KB
2025-11-13 15:30
Holding(s) in Company
English 21.0 KB
2025-11-10 08:25
Holding(s) in Company
English 21.0 KB
2025-11-04 18:30
Posting of Circular and Notice of General Meeting
English 41.5 KB
2025-11-04 08:20
Result of WRAP Retail Offer
English 25.2 KB
2025-10-30 08:21
WRAP Retail Offer for up to £300,000
English 34.2 KB
2025-10-30 08:17
Fundraising of up to £1,050,000
English 84.0 KB
2025-10-14 08:00
Inaphaea Commercial update
English 21.7 KB
2025-09-29 08:00
Half-year Report
English 291.2 KB
2025-09-18 08:00
Inaphaea Commercial Update
English 23.6 KB
2025-08-26 08:00
Commercial update
English 17.7 KB
2025-08-07 11:51
ValiRx Awarded Grant from Open University
English 16.2 KB

Automate Your Workflow. Get a real-time feed of all VALIRX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VALIRX PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VALIRX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.